Jupiter Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-533
| Closed | -$560K | – | 95 |
|
|
2024
Q3 | $560K | Hold |
533
| – | – | 0.29% | 63 |
|
|
2024
Q2 | $575K | Sell |
533
-38
| -7% | -$41K | 0.3% | 58 |
|
|
2024
Q1 | $546K | Buy |
571
+434
| +317% | +$415K | 0.29% | 60 |
|
|
2023
Q4 | $120K | Hold |
137
| – | – | 0.07% | 81 |
|
|
2023
Q3 | $109K | Buy |
+137
| New | +$109K | 0.07% | 83 |
|
|
2023
Q2 | – | Sell |
-137
| Closed | -$113K | – | 70 |
|
|
2023
Q1 | $113K | Sell |
137
-1,011
| -88% | -$831K | 0.1% | 63 |
|
|
2022
Q4 | $828K | Hold |
1,148
| – | – | 0.8% | 34 |
|
|
2022
Q3 | $790K | Buy |
1,148
+315
| +38% | +$217K | 0.79% | 32 |
|
|
2022
Q2 | $492K | Sell |
833
-315
| -27% | -$186K | 0.45% | 42 |
|
|
2022
Q1 | $801K | Buy |
1,148
+676
| +143% | +$472K | 0.5% | 43 |
|
|
2021
Q4 | $298K | Hold |
472
| – | – | 0.15% | 75 |
|
|
2021
Q3 | $294K | Hold |
472
| – | – | 0.14% | 77 |
|
|
2021
Q2 | $288K | Buy |
+472
| New | +$288K | 0.14% | 77 |
|